Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05253235 · ClinicalTrials.gov registry record · NA
Health and Resilience Projects: Foundations
A NA study of Substance Use, sponsored by University of Georgia.
- Recruiting
- Registry status
- NA
- Development phase
- 650
- Enrollment target
- 1
- Study location
NCT05253235: Recruiting NA study of Substance Use, sponsored by University of Georgia.
NCT05253235 is a NA study of Substance Use that is actively recruiting participants, run by University of Georgia. The registered enrollment target is 650 participants, below the 1,253-participant average among 88 other Substance Use trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05253235, a NA study of Substance Use, is actively recruiting participants, sponsored by University of Georgia.
- RECRUITING
- Registry status
- NA
- Development phase
- 650 participants
- Enrollment target
- 1
- Study location
Study Summary
The Health and Resilience Project (HARP): Foundations is investigating the efficacy of the Strong African American Families (SAAF) intervention in promoting the health and well being of African American adolescents. Youth age 10-13 and their primary caregivers are randomly assigned to receive SAAF or to a control group. Participants complete baseline and follow-up measures regarding vulnerability to substance use based on a neuroimmune model of stress coping.
Primary Outcome
Youth will complete the the Future-oriented Goals scale and Will's Self-Control scale. We will standardize scores from these two measures (mean =0, standard deviation =1) then average them together. We expect assignment to SAAF vs control to be associated with higher scores (more self-regulation).
Conditions Studied
Interventions
- BEHAVIORAL SAAF
- OTHER Receipt of parenting book
Study Locations (1)
Georgia
- Center for Family Research - Athens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 650 participants |
| Start Date | 2022-01-25 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT05253235 shows while recruiting
NCT05253235 is an interventional study that assigns participants to a tested intervention. The registered 650 participants enrollment target is mid-sized for trials with a published cap, below the 1,253-participant average among 88 other Substance Use trials with a reported enrollment target (48% lower).
The record links to 1 condition, with Substance Use appearing as the primary indexed condition, and to 2 interventions - of which SAAF is the first listed.
NCT05253235 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT05253235 about?
NCT05253235 is a clinical study titled "Health and Resilience Projects: Foundations". The Health and Resilience Project (HARP): Foundations is investigating the efficacy of the Strong African American Families (SAAF) intervention in promoting the health and well being of African American adolescents. Youth age 10-13 and their primary caregivers are randomly assigned to receive SAAF o...
What is the current status of trial NCT05253235?
This trial is currently recruiting. It is a NA study. The enrollment target is 650 participants. The study started on 2022-01-25. Estimated completion is 2027-12-31.
What conditions does trial NCT05253235 study?
This clinical trial studies the following conditions: Substance Use.
What interventions are being tested in trial NCT05253235?
The interventions under investigation include: SAAF (BEHAVIORAL), Receipt of parenting book (OTHER).
Who is sponsoring clinical trial NCT05253235?
This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05253235 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05253235's enrollment target sits among peer trials
650 13th of 88 higher than 76 of 88 other Substance Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Native Spirit: Significant Aim 3: Intervention
RECRUITING · NA
-
Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
RECRUITING · NA
-
Cultural Adaptation of Drug Treatment for DJJ Youth
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02934477 · 650 participants
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
- NCT04579120 · 650 participants
Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)
- NCT04875702 · 650 participants · Phase 4
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
- NCT05046600 · 650 participants
Registry of Arthrex Hand and Wrist Products
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI